OncoSec Medical Incorporated (ONCSQ)
OTCMKTS · Delayed Price · Currency is USD
0.00001
0.00 (0.00%)
At close: Aug 5, 2026
OncoSec Medical Market Cap
OncoSec Medical has a market cap or net worth of $60 as of August 10, 2026. Its market cap has increased by 900.00% in one year.
Market Cap
60.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since April 7, 2010, OncoSec Medical's market cap has decreased from 149.76K to 60.00, a decrease of -99.96%. That is a compound annual growth rate of -38.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 60.00 | 900.00% |
| Dec 30, 2024 | 6.00 | - |
| Dec 29, 2023 | 6.00 | -100.00% |
| Dec 30, 2022 | 4.99M | -86.78% |
| Dec 31, 2021 | 37.74M | -79.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Infinity Pharmaceuticals | 91.00 |
| American Oriental Bioengineering | 88.00 |
| RenovaCare | 87.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Genocea Biosciences | 59.00 |
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |